Skip to content

Author

Jing-Jing Lu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Empagliflozin Improves Atherosclerosis by Promoting Mitophagy in Endothelial Cells.

EMPA inhibits the progression of AS by activating Pink1/Parkin-mediated mitophagy, thereby improving mitochondrial function and alleviating endothelial injury and providing a novel basis for the cardiovascular protective mechanisms of EMPA.

Long-Long Yan, Jing-Jing Lu, Wen-Dong Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.